Calcium liquid Reagent

Products	Calcium liquid Reagent
Company	Hemagen Diagnostics, Inc.
Item	Calcium liquid Reagent
Features
Description	Intended for the quantitative determination of calcium in serum. Endpoint Reaction. Reaction complete within one minute, color developed is stable for eight hours. Wavelength: 650 nm. Linearity: 16 mg/dL (4.0 mmol/L)
Info	Hemagen Diagnostics, Inc. Customer Service: (877) 262-5978 Web site: http://www.hemagen.com/

TAG: Calcium liquid Reagent

Medicine Products:

Nucleus Chopper - P. Koch Magstim 200 Disposable Laser Fiber (For 12 Watt Laser)Single Use, 20 Gauge Illumination Probe

Breaking Medicine News(10 mins):Health News:Pitt study suggests craving hinders comprehension without your realizing it 2 Health News:Lilly Announces the First 300-unit Vial of Insulin 2 Health News:Lilly Announces the First 300-unit Vial of Insulin 3 Health News:Lilly Announces the First 300-unit Vial of Insulin 4 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5 Health News:Pitt study suggests craving hinders comprehension without you realizing it 2 Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2 Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3

[0] Pitt study suggests craving hinders comprehension without your realizing it [0] Lilly Announces the First 300-unit Vial of Insulin [0] Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management [0] Pitt study suggests craving hinders comprehension without you realizing it [1] Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange

Julie L. Novak Named Executive Director of Michigan State Medical Society Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 National Health Care Coalition Commends New Congress' Focus on Fighting Chronic Disease in House Stimulus Package Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009 Optelec and ShopLowVision.com Bring Life Back Into Focus at ATIA 2009 Orlando Patients' Bath Basins Increase Risk for Hospital-Acquired Infections

Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6 Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7 Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2 Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 1 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 2 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 3 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 4 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 5 Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 6 President Obama Misleads on Abortion Funding in Health Care Reform 54931 1 President Obama Misleads on Abortion Funding in Health Care Reform 54931 2 Kaiser Workers Launch Statewide Pickets 54929 1

[0] Hill-Rom Announces Appointment of James R. Giertz to Board of Directors [0] Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology [0] Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting